ID-Fish Technology, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
5
Ending by 2030
Nov 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 26, 2027The maintenance fee for Specific antigen sequences for COVID-19 and methods of use (US 11,940,449) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,927,801 | Nucleic acid probes and methods for detecting Plasmodium parasites In force · From the USPTO record | In force | From the USPTO record | |
| US 8,592,568 | Nucleic acid probes and methods for detecting plasmodium parasites In force · From the USPTO record | In force | From the USPTO record | |
| US 10,077,480 | Nucleic acid probes and methods for detecting plasmodium parasites In force · From the USPTO record | In force | From the USPTO record | |
| US 8,323,901 | Nucleic acid probes and methods for detecting plasmodium parasites In force · From the USPTO record | In force | From the USPTO record | |
| US 8,758,990 | Methods for detecting and differentiating Mycobacterium genus and Mycobacterium avium complex in a sample or culture In force · From the USPTO record | In force | From the USPTO record | |
| US 8,632,963 | Method for improving cell permeability to foreign particles In force · From the USPTO record | In force | From the USPTO record | |
| US 10,167,522 | Nucleic acid probes and methods for detecting plasmodium knowlesi In force · From the USPTO record | In force | From the USPTO record | |
| US 10,718,767 | Species Specific Antigen Sequences for Tick-Borne Relapsing Fever (TBRF) and Methods of Use In force · High confidence | In force | High confidence | |
| US 11,353,457 | Species Specific Antigen Sequences for Tick-Borne Relapsing Fever (TBRF) and Methods of Use In force · High confidence | In force | High confidence | |
| US 12,298,312 | Detection of Lyme disease In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 4 no status recorded